AG00064I

101975-10-4 | 3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-

Chemical structure of 3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-, CAS 101975-10-4
AG00064I
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 101975-10-4
Catalog Number AG00064I(AGN-PC-0JK7CO)
Chemical Name 3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-
IUPAC Name 3-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one
InChI InChI=1S/C12H10F2N2O3/c1-18-10-6-7(2-4-9(10)19-12(13)14)8-3-5-11(17)16-15-8/h2-6,12H,1H3,(H,16,17)
InChI Key HJMQDJPMQIHLPB-UHFFFAOYSA-N
MDL Number MFCD00867059
Molecular Formula C12H10F2N2O3
Molecular Weight 268.2162
SMILES O=C1C=CC(C2=CC=C(OC(F)F)C(OC)=C2)=NN1
UNII TQ358GWH6Y
Synonyms
6-(4-difluoromethoxy-3-methoxyphenyl)-3(2H)pyridazinone, zardaverine, zardaverine, 101975-10-4, Zardaverina, Zardaverinum, Zardaverine [INN], 6-(4-DIFLUOROMETHOXY-3-METHOXY-PHENYL)-2H-PYRIDAZIN-3-ONE, Zardaverinum [INN-Latin], UNII-TQ358GWH6Y, Zardaverina [INN-Spanish], C12H10F2N2O3, 6-(4-(Difluoromethoxy)-3-methoxyphenyl)-3(2H)-pyridazinone, TQ358GWH6Y, CHEMBL313842, 6-[4-(difluoromethoxy)-3-methoxyphenyl]pyridazin-3(2H)-one, CHEBI:46548, HJMQDJPMQIHLPB-UHFFFAOYSA-N, 6-(4-Difluoromethoxy-3-methoxyphenyl)-3(2H)-pyridazinone, NCGC00016106-04, 3(2H)-Pyridazinone,6-[4-(difluoromethoxy)-3-methoxyphenyl]-, CAS-101975-10-4, 3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]- [CAS], DSSTox_CID_22559, DSSTox_RID_80048, DSSTox_GSID_42559, 6-(4-(difluoromethoxy)-3-methoxyphenyl)pyridazin-3(2H)-one, 6-[4-(Difluoromethoxy)-3-methoxyphenyl]-3(2H)-pyridazinone, SMR000449313, SR-01000076204, Zaradaverine, 1mkd, 1xor, Tocris-1046, ACMC-20ccb1, AC1L1KZT, AC1Q6BYY, Prestwick0_000977, Prestwick1_000977, Prestwick2_000977, Prestwick3_000977, Lopac-Z-3003, UPCMLD-DP159, Lopac0_001260, SCHEMBL13334, BSPBio_001013, BSPBio_001346, KBioGR_000066, KBioSS_000066, MLS000758207, MLS001401422, SPBio_002924, BPBio1_001115, DTXSID8042559, SCHEMBL14810549, UPCMLD-DP159:001, UPCMLD-DP159:002, BDBM14769, CTK4A0496, KBio2_000066, KBio2_002634, KBio2_005202, KBio3_000131, KBio3_000132, 3-pyridazinol, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-, 6-(4-difluoromethoxy-3-methoxyphenyl)-3(2H)pyridazinone, Bio2_000066, Bio2_000546, HMS1361D08, HMS1571C15, HMS1791D08, HMS1989D08, HMS2051O09, HMS2090L06, HMS2098C15, HMS2235H08, HMS3267C08, HMS3370L18, HMS3393O09, HMS3402D08, HMS3676C09, HMS3715C15, BCP06509, ZINC9230249, Tox21_110307, 4165AH, BS0210, MFCD00867059, AKOS024456348, Tox21_110307_1, Zardaverine phosphodiesterase inhibitor, CCG-100782, CCG-205334, CS-1011, DB02918, NC00032, Zardaverine, phosphodiesterase inhibitor, IDI1_033816, NCGC00016106-01, NCGC00016106-02, NCGC00016106-03, NCGC00016106-05, NCGC00016106-06, NCGC00016106-07, NCGC00016106-08, NCGC00016106-09, NCGC00016106-10, NCGC00016106-11, NCGC00016106-13, NCGC00024963-01, NCGC00024963-02, NCGC00024963-03, NCGC00024963-04, NCGC00024963-05, CC-35668, CPD000449313, HY-15485, SAM001247053, SBI-0051227.P002, LS-171799, AB00513983, EU-0101260, FT-0631019, W-5158, Z 3003, AB00513983-03, C-16835, J-000529, SR-01000076204-1, SR-01000076204-3, SR-01000076204-5, BRD-K37561857-001-04-9, BRD-K37561857-001-06-4, BRD-K37561857-001-13-0, 6-(4-difluoromethoxy-3-methoxy-phenyl)-3[2h]-pyridazinone, 3-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-2,3-dihydropyridazin-3-one, 6-(3,4-Dimethoxy-phenyl)-4,5-dimethyl-4,5-dihydro-2H-pyridazin-3-one, D0F0CS, CID5723, AR-1F5139, C12-H10-F2-N2-O3, A12550, C066436, 102433-41-0, ZAR,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited